FATE logo

Fate Therapeutics, Inc. (FATE)

Profile

Full Name

Fate Therapeutics, Inc.

Ticker

NASDAQ: FATE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 1, 2013

Indexes

Not included

Website

https://www.fatetherapeutics.com

Employees

181

Key Details

Price

$0.97(-3.96%)

Market cap

$111.87M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$13.63M(-78.55% YoY)

Annual EPS

-$1.64(0.00% YoY)

PE ratio

-

Next earnings date

Nov 11, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.97
    FATE price is $0.97

    30-Day Relative Volume

    0.83
    FATE 30-day relative volume is 0.83

    Price Performance

    Price Most recent change

    -3.96%
    FATE price was down -3.96% on Sep 8, 2025

    Price YTD change

    -41.21%
    FATE price is down -41.21% since January 1st

    Price 1-year change

    -71.88%
    FATE price is down -71.88% year-on-year

    Price 3-year change

    -96.55%
    FATE price is down -96.55% over the past 3 years

    Price Range

    Price All-time high

    $121.16
    FATE price is currently -99.20% below its historical high of $121.16

    Price 3-year low

    $0.66
    FATE price is currently +46.97% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $111.87M
    FATE market capitalization is $111.87 million

    Market cap 3-year change

    -95.9%
    FATE market capitalization is down -95.9% over the past 3 years

    Market cap All-time high

    $10.90B
    FATE market capitalization is currently -98.97% below its historical high of $10.90 billion

    Market cap sector rank

    42.74%
    FATE market capitalization is higher than 42.74% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.27%
    FATE shares outstanding is up +1.27% year-on-year

    Shares Outstanding 3-Year Change

    +18.9%
    FATE shares outstanding is up +18.9% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.98
    FATE beta is 0.98

    200-day SMA

    $1.32
    FATE price is currently -26.49% below its 200-day simple moving average

    50-day SMA

    $1.10
    FATE price is currently -12.09% below its 50-day simple moving average

    RSI

    40.15
    FATE 14-day relative strength index is 40.15

    Volume

    0.83
    FATE 30-day relative volume is 0.83

    ATR

    $0.08
    FATE average true range is $0.08

    10-day Historical Volatility

    47.85%
    FATE 10-day historical volatility is 47.85%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $13.63M
    FATE annual revenue is $13.63 million

    Revenue Analysts estimate

    $7.03M
    FATE annual revenue is currently +93.79% higher than the consensus analysts' forecast

    Revenue 1-year change

    -78.55%
    FATE annual revenue is down -78.55% year-on-year

    Revenue Sector rank

    50.42%
    FATE annual revenue is higher than 50.42% of companies in Healthcare sector

    EPS

    EPS

    -$1.64
    FATE annual earnings per share is -$1.64

    EPS Analysts estimate

    -$1.08
    FATE annual earnings per share is currently +51.40% higher than the consensus analysts' forecast

    EPS 1-year change

    0%
    FATE annual earnings per share has remained unchanged year-on-year

    EPS Sector rank

    40.76%
    FATE annual earnings per share is higher than 40.76% of companies in Healthcare sector

    Profit

    Gross profit

    -$5.33M
    FATE annual gross profit is -$5.33 million

    Gross margin

    -39.11%
    FATE annual gross profit margin is -39.11%

    Operating profit

    -$195.54M
    FATE annual operating income is -$195.54 million

    Operating margin

    -1434.52%
    FATE annual operating profit margin is -1434.52%

    Net income

    -$186.26M
    FATE annual net profit is -$186.26 million

    Net margin

    -1366.46%
    FATE annual net profit margin is -1366.46%

    Expenses

    Total expenses

    $209.17M
    FATE annual total expenses is $209.17 million

    Operating expenses

    $209.17M
    FATE annual total operating expenses is $209.17 million

    Cost of goods sold

    $18.96M
    FATE annual cost of goods sold is $18.96 million

    Selling, general & administrative expenses

    $74.17M
    FATE annual SGA is $74.17 million

    Depreciation and amortization

    $18.96M
    FATE annual depreciation & amortization is $18.96 million

    Interest expense

    $0.00
    FATE annual interest expense is $0.00

    Income tax

    $0.00
    FATE annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$195.54M
    FATE annual earnings before interest & taxes is -$195.54 million

    EBITDA

    -$176.58M
    FATE annual EBITDA is -$176.58 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $440.69M
    FATE annual total assets is $440.69 million

    Non current assets

    $148.78M
    FATE annual long term assets is $148.78 million

    Current assets

    $291.91M
    FATE annual total current assets is $291.91 million

    Cash and cash equivalents

    $36.06M
    FATE annual cash & cash equivalents is $36.06 million

    Accounts receivable

    $3.54M
    FATE annual accounts receivable is $3.54 million

    Inventory

    $0.00
    FATE annual inventory is $0.00

    Liabilities

    Total liabilities

    $121.97M
    FATE annual total liabilities is $121.97 million

    Long term liabilities

    $83.45M
    FATE annual total long term liabilities is $83.45 million

    Current liabilities

    $38.52M
    FATE annual total current liabilities is $38.52 million

    Accounts payable

    $9.37M
    FATE annual accounts payable is $9.37 million

    Debt

    Total debt

    $85.27M
    FATE annual total debt is $85.27 million

    Total debt 1-year change

    -17.65%
    FATE annual total debt is down -17.65% year-on-year

    Long term debt

    $77.85M
    FATE annual long term debt is $77.85 million

    Short term debt

    $7.42M
    FATE annual short term debt is $7.42 million

    Equity & Capital

    Shareholders equity

    $318.73M
    FATE annual stockholders equity is $318.73 million

    Book value

    $318.72M
    FATE annual book value is $318.72 million

    Retained earnings

    -$1.40B
    FATE annual retained earnings is -$1.40 billion

    Working capital

    $253.39M
    FATE annual working capital is $253.39 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$122.87M
    FATE annual cash flow from operations is -$122.87 million

    Cash from operations 1-year change

    +7.1%
    FATE annual cash flow from operations is up +7.1% year-on-year

    Cash from investing

    $12.22M
    FATE annual cash flow from investing activities is $12.22 million

    Cash from investing 1-year change

    -89.16%
    FATE annual cash flow from investing activities is down -89.16% year-on-year

    Cash from financing

    $99.89M
    FATE annual cash flow from financing activities is $99.89 million

    Cash from financing 1-year change

    +117420%
    FATE annual cash flow from financing activities is up +117420% year-on-year

    CAPEX

    CAPEX

    $730.00K
    FATE annual capital expenditures is $730.00 thousand

    CAPEX 1-year change

    -88.14%
    FATE annual capital expenditures is down -88.14% year-on-year

    Free Cash Flow

    Free cash flow

    -$123.60M
    FATE annual free cash flow is -$123.60 million

    Free cash flow 1-year change

    +10.7%
    FATE annual free cash flow is up +10.7% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -39.11%
    FATE annual gross profit margin is -39.11%

    Operating margin

    -1434.52%
    FATE annual operating profit margin is -1434.52%

    Net margin

    -1366.46%
    FATE annual net profit margin is -1366.46%

    ROA & ROE

    ROA

    -39.34%
    FATE annual return on assets is -39.34%

    ROE

    -54.21%
    FATE annual return on equity is -54.21%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    FATE price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    FATE price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.43
    FATE price to book ratio is 0.43

    PB ratio Sector rank

    23.06%
    FATE price to book ratio is higher than 23.06% of companies in Healthcare sector

    PS Ratio

    PS ratio

    13.21
    FATE price to sales ratio is 13.21

    PS ratio Sector rank

    76.67%
    FATE price to sales ratio is higher than 76.67% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    -$29.63M
    FATE enterprise value is -$29.63 million

    Enterprise value Sector rank

    3.46%
    FATE enterprise value is higher than 3.46% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.18
    FATE EV/EBITDA is 0.18

    EV/EBITDA Sector rank

    67.23%
    FATE EV/EBITDA is higher than 67.23% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.58
    FATE annual current ratio is 7.58

    Quick ratio

    7.58
    FATE annual quick ratio is 7.58

    Leverage

    Debt to equity

    0.00
    FATE annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    FATE annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    2
    FATE piotroski f-score is 2

    Altman Z-Score

    -4.63
    FATE altman z-score is -4.63

    Analyst ratings

    Recent major analysts updates

    Aug 13, 25 Wells Fargo
    Equal-Weight
    Jun 12, 25 Needham
    Hold
    May 14, 25 Needham
    Hold
    May 14, 25 Barclays
    Overweight
    May 14, 25 Baird
    Neutral
    Mar 6, 25 Wells Fargo
    Equal-Weight
    Mar 6, 25 Wedbush
    Neutral
    Mar 6, 25 Stifel
    Hold
    Mar 6, 25 Needham
    Hold
    Nov 19, 24 Needham
    Hold

    Institutional Ownership

    Screeners with FATE included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Fate Therapeutics, Inc.?
    • Does Fate Therapeutics, Inc. pay dividends?
    • What sector is Fate Therapeutics, Inc. in?
    • What industry is Fate Therapeutics, Inc. in?
    • What country is Fate Therapeutics, Inc. based in?
    • When did Fate Therapeutics, Inc. go public?
    • Is Fate Therapeutics, Inc. in the S&P 500?
    • Is Fate Therapeutics, Inc. in the NASDAQ 100?
    • Is Fate Therapeutics, Inc. in the Dow Jones?
    • When was Fate Therapeutics, Inc.'s last earnings report?
    • When does Fate Therapeutics, Inc. report earnings?

    What is the ticker symbol for Fate Therapeutics, Inc.?

    The ticker symbol for Fate Therapeutics, Inc. is NASDAQ:FATE

    Does Fate Therapeutics, Inc. pay dividends?

    No, Fate Therapeutics, Inc. does not pay dividends

    What sector is Fate Therapeutics, Inc. in?

    Fate Therapeutics, Inc. is in the Healthcare sector

    What industry is Fate Therapeutics, Inc. in?

    Fate Therapeutics, Inc. is in the Biotechnology industry

    What country is Fate Therapeutics, Inc. based in?

    Fate Therapeutics, Inc. is headquartered in United States

    When did Fate Therapeutics, Inc. go public?

    Fate Therapeutics, Inc.'s initial public offering (IPO) was on October 1, 2013

    Is Fate Therapeutics, Inc. in the S&P 500?

    No, Fate Therapeutics, Inc. is not included in the S&P 500 index

    Is Fate Therapeutics, Inc. in the NASDAQ 100?

    No, Fate Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Fate Therapeutics, Inc. in the Dow Jones?

    No, Fate Therapeutics, Inc. is not included in the Dow Jones index

    When was Fate Therapeutics, Inc.'s last earnings report?

    Fate Therapeutics, Inc.'s most recent earnings report was on August 12, 2025

    When does Fate Therapeutics, Inc. report earnings?

    The next expected earnings date for Fate Therapeutics, Inc. is November 11, 2025
    On this page